StockNews.AI
LMAT
StockNews.AI
9 hrs

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

1. LeMaitre will release Q3 2025 financial results on November 6. 2. A conference call is scheduled for the same day for discussions. 3. LeMaitre specializes in peripheral vascular disease treatments. 4. The disease affects over 200 million people globally, highlighting market potential. 5. Financial performance will indicate future company outlook.

3m saved
Insight
Article

FAQ

Why Bullish?

Financial results announcements can lead to positive market reactions, especially if growth is expected.

How important is it?

Upcoming earnings report will provide critical insights into company performance and potential growth.

Why Short Term?

Q3 results may cause immediate market movements based on performance insights.

Related Companies

TNDMISRGABMD
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related News